BIO-FD&C CO. LTD
KKRX:2511209,700.00
KRW
-220.00
(-2.22%)
ISIN
KR7251120002
Return %
Stock
S&P 500
1Y
-42.26
13.14
3Y
-21.14
80.78
5Y
- -
67.74
Capital Structure
KRW
•
in mil. unless spec.Working Capital
KRW
•
in mil. unless spec.Growth Rates
KRW
•
in mil. unless spec.Quarterly Revenue
KRW
•
in mil. unless spec.Quarterly Earnings Per Share
KRW
•
in mil. unless spec.Quarterly Dividends Per Share
KRW
•
in mil. unless spec.Company Description
- Full Time Employees
- 78
- Sector
- Distribution services
- Industry
- Medical distributors
- Address
- Inchon South Korea
- IPO Date
- Feb 21, 2022
- Website
- biofdnc.com
- Similar Companies
- Business
- BIO-FD&C Co., Ltd. is a South Korea-based biotechnology company specializing in the research, development, and commercialization of plant cell-derived active ingredients, recombinant biomimetic peptides, and bio-pharmaceutical materials for the cosmetics, aesthetic medicine, and healthcare industries. Founded in 2005 and headquartered in Incheon, South Korea, the company operates advanced research, development, and manufacturing facilities across the Songdo Bio Cluster and Hwasun, Jeollanam-do, serving domestic and international markets across Asia, Europe, and North America. The company operates primarily through its Cosmeceuticals, Biomaterials, and Bio-pharma R&D business segments. BIO-FD&C Co., Ltd. develops and manufactures a comprehensive portfolio of proprietary active ingredients and customized formulations, including: plant callus and plant stem cell extracts derived from diverse botanical species, such as edelweiss, rose, and taxus cultures; recombinant growth factors and biomimetic peptides, including Epidermal Growth Factor (EGF), Fibroblast Growth Factor (FGF), Insulin-like Growth Factor (IGF), Transforming Growth Factor (TGF), and specialized anti-aging, skin-brightening, and wrinkle-reducing peptides; plant-based recombinant proteins utilizing advanced expression systems for dermatological and regenerative applications; cosmeceutical and derma-cosmetic raw materials supplied to global original design manufacturers (ODMs), original equipment manufacturers (OEMs), and brand owners; finished anti-aging, hair-loss prevention, and skin-barrier restorative formulations; and contract development and manufacturing organization (CDMO) services for custom peptide synthesis, protein engineering, and plant cell culture bioprocessing. In recent developments, BIO-FD&C Co., Ltd. has expanded its international footprint and production capabilities through a strategic alliance and equity partnership with global fragrance and beauty active leader Givaudan, aimed at co-developing and distributing novel plant cell culture ingredients worldwide. The company has also advanced its research pipeline into plant-derived therapeutic biomaterials, veterinary therapeutics, and medical aesthetic applications, scaling up continuous plant cell culture bioreactor capacities at its production centers and securing strategic joint research agreements to expand the commercial application of its recombinant growth factor platforms into functional food supplements and advanced dermatological healthcare solutions.